• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Tetracyclines and niacinamide in canine dermatology (Proceedings)

November 1, 2010
Danny W. Scott, DVM, DACVD

The tetracyclines were initially used as bacteriostatic antibiotics. Niacinamide (the amide of niacin) is a vasodilator. These agents also have some interesting in vitro and in vivo anti-inflammatory and immunomodulatory properties.

The tetracyclines were initially used as bacteriostatic antibiotics. Niacinamide (the amide of niacin) is a vasodilator. These agents also have some interesting in vitro and in vivo anti-inflammatory and immunomodulatory properties:

Tetracyclines

      1. Decrease T-lymphocyte blastogenic response to mitogens.

      2. Decrease antibody production.

      3. Decrease complement activation.

      4. Decrease chemotactic responses of neutrophils.

      5. Decrease chemotactic responses of eosinophils.

Advertisement

      6. Decrease prostaglandin synthesis.

      7. Inhibit collagenase.

      8. Inhibit lipase.

Niacinamide

      1. Decrease T-lymphocyte blastogenic responses to mitogens.

      2. Inhibit phosphodiesterase.

      3. Inhibit proteases.

      4. Prevent mast cell degranulation.

      5. Block antigen/IgE-induced histamine release.

The combination of tetracycline and niacinamide was initially used to treat certain canine autoimmune diseases: cutaneous (discoid) lupus erythematosus, pemphigus erythematosus, pemphigus foliaceus, and bullous pemphigoid. It was subsequently reported to be efficacious in some cases of lupoid onychitis, vasculitis, vesicular cutaneous lupus erythematosus (collies and shelties), exfoliative lupus erythematosus (German shorthair pointers), uveodermatologic syndrome (aka Vogt-Koyanagi-Harada syndrome), mucous membrane pemphigoid, various sterile granulomatous disorders (sterile granuloma-pyogranuloma syndrome; panniculitis; metatarsal fistulae), and cutaneous histiocytosis. Tetracycline and niacinamide can be used as a steroid-sparing agent. The combination is not effective for atopic dermatitis.

The traditional dosing of tetracycline and niacinamide is as follows: 250 mg of each, q8h, for a dog <10 kg; 500 mg of each, q8h, for a dog >10 kg. The combination is usually well-tolerated, with gastrointestinal side effects (vomiting, diarrhea, anorexia, lethargy) being the most common (and usually due to the niacinamide). These can be minimized by giving the agents with food, but not dairy products and mineral supplements. Some dogs may be maintained on twice or even once-a-day dosing. It appears that doxycycline (5 mg/kg q12h) can be substituted for tetracycline. Onset of clinical benefit is often slow and gradual, and 3 to 8 weeks of treatment is recommended before efficacy is assessed. Long-term treatment of dogs with tetracycline and niacinamide did not interfere with antibody responses to distemper and parvovirus vaccinations.

Remember: Niacinamide is not niacin. Large doses of niacin produce vasodilation, flushing, hypotension, tachycardia, and gastrointestinal side effects.

References

Beningo KE, Scott DW, Miller WH, et al. Observations on the use of tetracycline and niacinamide as antipruritic agents in atopic dogs. Canadian Veterinary Journal 1999; 40:268.

Mueller RS, Fieseler KV, Bettenay SV, et al. Influence of long-term treatment with tetracycline and niacinamide on antibody production in dogs with discoid lupus erythematosus. American Journal of Veterinary Research 2002; 63:491.

Mueller RS, Rosychuk RAW, Jonas LD. A retrospective study regarding the treatment of lupoid onychodystrophy in 30 dogs and literature review. Journal of the American Animal Hospital Association 2003; 39:139.

Murayama N, et al. Tetracycline and niacinamide for the treatment of idiopathic sterile granuloma and pyogranuloma in two dogs. Japanese Journal of Veterinary Dermatology 2003; 9:127.

Scott DW, Miller Wh, Griffin CE. Muller & Kirk's Small Animal Dermatology, 6th ed. WB Saunders, Philadelphia, 2001; p 677.

White SD, Rosychuk RAW, Reinke SI, et al. Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs. Journal of the American Veterinary Medical Association 1992; 200:1497.

Related Content:

Dermatology
Expert shares pet care tips for springtime
Expert shares pet care tips for springtime
Molecular allergology: what you need to know about the future of allergy testing
Molecular allergology: what you need to know about the future of allergy testing
Topical therapy and immunotherapy can save time and frustration with dermatology cases
Topical therapy and immunotherapy can save time and frustration with dermatology cases

Advertisement

Latest News

An update on copper concerns in pet foods

Dental hacks to make every case more manageable

Q&A with a keynote: Walter Brown, RVTg, VTS, ECC

News wrap-up: This week’s headlines, plus dvm360® launches its first CE podcast

View More Latest News
Advertisement